Aberrant accumulation of immunometabolite S-2HG mediates activation and migration of CD8+ T lymphocytes, which may present a novel mechanism and therapeutic target underlying exacerbation effect of perioperative ischemic stroke. The gene discussed is CD8A; the disease is ischemic stroke.